Group items tagged

The global Contrast Media Market size is expected to reach USD 7.2 billion by 2028, according to a new report published by Grand View Research, Inc.

The global digital pathology market size is expected to reach USD 1.5 billion by 2028, according to a new report by Grand View Research, Inc.

North America leads the global heart failure drugs market in 2018 followed by Europe. The US dominates the market owing to the presence of a majority of the heart failure drugs manufacturers in the region. However, the fastest growth rate is anticipated to be in the APAC region due to the presence of large heart failure patient population and availability of wide range of drugs. Most of the revenue is generated from the leading players in the market with dominant sales from Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, Bayer AG, and Pfizer Inc.

With growing concerns over the spread of Omicron variant, the UK has signed two contracts with drug majors Pfizer Inc. and Merck & Co to buy 4.25 million courses of antivirals for the NHS patients. The move is aimed at reducing hospitalisations and easing pressures on the NHS. The two new contracts are for 1.75 million additional courses of Merck Sharp and Dohme's (MSD) molnupiravir (Lagevrio®) and 2.5 million additional courses of PF-07321332/ritonavir (Paxlovid™) from Pfizer. The ordered drugs will be available from early next year and both are expected to be effective against Omicron. The recent order is in addition to the 480,000 courses of molnupiravir and 250,000 courses of PF-07321332/ritonavir procurement announced in October.

Researchers from the University of Oxford today (December 8) started recruiting for a clinical trial to test novel antiviral Covid-19 treatments for early use in the illness by people in the community and those who are at higher risk of complications. Partnering with the National Institute for Health Research (NIHR), colleagues in several UK universities, and the NHS UK-wide, the Platform Adaptive trial of NOvel antiviRals for eArly treatMent of Covid-19 In the Community (PANORAMIC), is a national priority trial, and will be open to participants from across the UK. The first treatment to be tested by the UK Antiviral Taskforce will be molnupiravir, a Covid antiviral pill already licensed by the MHRA. Britain became the first country in the world to approve molnupiravir, which was jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in November.

Rosalind Brewer, the CEO of Walgreens Boots Alliance, Inc. (WBA), the parent company of Boots UK, has resigned from her position after serving for less than three years. The prominent US pharmaceutical company is currently in the process of searching for her successor. Ginger Graham, the lead independent director, has been appointed as the interim CEO. "WBA's board of directors and Brewer have mutually agreed on her departure as chief executive and board member," the company said in a statement. Brewer officially stepped down from her roles as chief executive and director on Thursday (Aug. 31). She assumed the CEO role in March 2021, succeeding Executive Chairman Stefano Pessina. Prior to this, Brewer held the position of CEO at Starbucks. The leadership change aligns with WBA's shift towards becoming a broader healthcare company, a strategic move initiated by Brewer and her team in October 2021.

38th Annual Series Emergency Medicine & Acute Care Course is organized by The Center for Medical Education, Inc. from Jun 14 - 17, 2023 in New York City, USA.

The global surgical scissors market size is expected to reach USD 552.94 million by 2030, according to a new report by Grand View Research, Inc., registering at a CAGR of 6.56 % from 2022 to 2030.

The global film dressing market size is anticipated to reach USD 2,165.41 million by 2030, registering a CAGR of 4.54% during the forecast period, according to a new report by Grand View Research, Inc.

The global clinical trial investigative site network market size is expected to reach USD 12.5 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc.

The global medical terminology software market size is expected to reach USD 2.34 billion by 2030, registering a CAGR of 10.1% during the forecast period, according to a new report by Grand View Research, Inc.

303: Tuberculosis (N) is organized by Medical Education Systems (MedEdSys), Inc. Identify the CDC guidelines for mandatory reporting requirements of TB.

Japanese pharmaceutical firm Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed with data showing it can slow the brain-wasting disease for people with early symptoms, potentially getting the treatment to patients next year. It remains unclear how widely the drug developed with U.S. biotech Biogen Inc will be used due to uncertainty over insurance coverage, including the U.S. government's Medicare plan for people age 65 and over, potential side effects and cost. One Wall Street analyst told Reuters news agency that he is not counting on measurable sales until 2024. Several estimated lecanemab may be priced at around $20,000 per year. "Most people who this (drug) would apply to are on Medicare, and most private payers look to Medicare as they make their own (coverage) decisions. So there's a massive roadblock in the way of all who could benefit from this treatment," said Robert Egge, Alzheimer's Association chief public policy officer. Eisai confirmed on Tuesday (November 30) that lecanemab - an antibody designed to remove sticky deposits of a protein called amyloid beta from the brain - reduced the rate of cognitive decline on a clinical dementia scale by 27% compared to a placebo. It also gave new details on side effects including a dangerous type of brain swelling and brain bleeding.

Prostate Cancer: Current Approaches in Nursing Care and Patient Management is organized by Wild Iris Medical Education, Inc

200: Principles of EEG (N) is organized by Medical Education Systems (MedEdSys), Inc. Identify the advantages and limitations of EEG in clinical use.

Emergency Medicine and Infectious Diseases: Current Issues and Common Challenges is organized by American Medical Seminars, Inc. from Jun 19 - 22, 2023 in Sarasota, Florida, USA

AMS 2023: Internal Medicine and Endocrinology: A Practical Approach is organized by American Medical Seminars, Inc. and will be held from May 22 - 24, 2023 in Florida.

AMS 2023: Current Strategies in Primary Care: Endocrinology, Neurology, and Sports Medicine is organized by American Medical Seminars, Inc. and will be held from Apr 17 - 20, 2023 in Florida, USA

Family Medicine and Internal Medicine: An Evidence-Based Approach is organized by American Medical Seminars (AMS), Inc. from Mar 06 - 09, 2023 in Sarasota, Florida, USA

Suicide Prevention and Screening is organized by Wild Iris Medical Education, Inc. to Express an understanding of common myths related to suicide